Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
FUJIFILM announced an initial $10M USD investment to establish a full scale, fully integrated continuous processing facility for non-GMP manufacture of biopharmaceuticals at its Billingham, UK location.
read more
Enable Injections has entered into a multi-product development agreement with Sanofi S.A.
read more
AGC Biologics announced the appointment of Kasper Møller to the role of Chief Technical Officer.
read more
ACG Inspection recently completed the supply, installation, and validation of its 1,000th Track & Trace line.
read more
Boehringer Ingelheim and the University of Dundee have extended their collaboration to develop new medicines that target and destroy key cancer causing proteins.
read more
Nebula Genomics has signed an agreement for EMD Serono to access genomic data on Nebula’s blockchain-based network for genomic data sharing.
read more
Hoth Therapeutics has signed contracts with providers for production of their BioLexa therapeutic, in preparation for upcoming toxicology and clinical studies.
read more
Debiopharm and Ipsen announced renewal of their Decapeptyl® agreement, which extends their partnership through 2034 for the development, manufacturing and distribution of Decapeptyl®.
read more
Amcor has announced the successful completion of its acquisition of Bemis Company.
read more
Crown Bioscience announced four new preclinical translational NASH models in development.
read more
On 22 May 2019 Amgen announced a recommended public cash offer to the shareholders of Nuevolution to tender all their shares in Nuevolution to Amgen for SEK 32.50 per share in cash.
read more
HBM and Erasmus MC, University Medical Center Rotterdam have signed a 10-year MOU to enable a range of joint research activities to develop next generation biotherapeutics.
read more
nanoComposix recently received its Drug Manufacturing License from the Food and Drug Branch of the State of California Department of Public Health.
read more
Camargo Pharmaceutical Services announced it will acquire InSymbiosis, a Canadian drug development partner which improves how biopharma companies outsource R&D.
read more
Lonza announced an investment in a major expansion of Highly Potent API (HPAPI) capacity at its Visp, CH site.
read more